United States · Wires & real time · Business Wire

Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock

Published by Business Wire · United States 15 h ago

Blackstone Life Sciences (“BXLS”) today announced a $455 million collaboration with Boston Scientific Corporation (NYSE: BSX) to co-fund the development of ...

Read the full article on Business Wire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.businesswire.com)

Also worth reading

PR Newswire

Blackstone Life Sciences Announces $455 Million Collaboration to Co-Fund Development of Boston Scientific VITALYST™ Heart Pump for Patients with Cardiogenic Shock

Share

Also worth reading

MemorialCare Expands Advanced GERD Care with TIF and cTIF Procedures

8 innovative gifts meant to change up how we drive, cook, sleep and more

Rethinking AI in Enterprise Intelligence

CNBC TV Video Segments Now Available Through MT Newswires